GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » 14-Day RSI

Novan (NOVNW) 14-Day RSI : N/A (As of Mar. 04, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Novan 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2025-03-04), Novan's 14-Day RSI is N/A.

The industry rank for Novan's 14-Day RSI or its related term are showing as below:

NOVNW's 14-Day RSI is not ranked *
in the Biotechnology industry.
Industry Median: 43.66
* Ranked among companies with meaningful 14-Day RSI only.

Competitive Comparison of Novan's 14-Day RSI

For the Biotechnology subindustry, Novan's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novan's 14-Day RSI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novan's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Novan's 14-Day RSI falls into.



Novan  (OTCPK:NOVNW) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novan  (OTCPK:NOVNW) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Novan 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Novan's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Novan Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 64, Pittsboro, NC, USA, 27312
NVN Liquidation Inc Formerly Novan Inc is a dermatology company focused on developing and commercializing therapeutic products for skin diseases. It is developing SB206 as a topical prescription gel for the treatment of viral skin infections. The company's product portfolio includes; Wynzora Cream for the treatment of plaque psoriasis, Rhofade cream for the treatment of persistent facial erythema, Minolira tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients, Cloderm cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Sitavig tablets for the treatment of recurrent herpes labialis in immunocompetent adults, and Nuvail nail solution for managing signs and symptoms of nail dystrophy.

Novan Headlines

From GuruFocus

Novan Inc To Acquire EPI Health LLC Call Transcript

By GuruFocus Research 02-14-2024

Novan to Report Full Year 2022 Financial Results on March 30, 2023

By sperokesalga sperokesalga 03-23-2023

Q1 2023 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2022 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan Inc To Host Corporate Update Call Transcript

By GuruFocus Research 02-14-2024

Novan Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Q2 2022 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan Focuses Strategic Direction and Announces Restructuring

By sperokesalga sperokesalga 05-31-2023

Novan Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024